Filter News
Area of Research
- (-) Clean Energy (31)
- (-) Neutron Science (22)
- (-) Nuclear Science and Technology (14)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (39)
- Climate and Environmental Systems (1)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (7)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (5)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (9)
- Materials (27)
- Materials for Computing (4)
- National Security (23)
- Sensors and Controls (1)
- Supercomputing (99)
News Topics
- (-) Artificial Intelligence (14)
- (-) Big Data (7)
- (-) Biomedical (19)
- (-) Frontier (3)
- (-) Mercury (3)
- (-) Molten Salt (5)
- (-) Quantum Computing (1)
- (-) Security (8)
- (-) Space Exploration (10)
- (-) Transformational Challenge Reactor (5)
- 3-D Printing/Advanced Manufacturing (85)
- Advanced Reactors (15)
- Bioenergy (30)
- Biology (16)
- Biotechnology (5)
- Buildings (36)
- Chemical Sciences (16)
- Clean Water (10)
- Climate Change (22)
- Composites (18)
- Computer Science (37)
- Coronavirus (21)
- Critical Materials (9)
- Cybersecurity (10)
- Decarbonization (34)
- Energy Storage (75)
- Environment (59)
- Exascale Computing (2)
- Fossil Energy (3)
- Fusion (10)
- Grid (40)
- High-Performance Computing (8)
- Hydropower (2)
- Isotopes (6)
- Machine Learning (10)
- Materials (46)
- Materials Science (51)
- Mathematics (3)
- Microelectronics (1)
- Microscopy (10)
- Nanotechnology (17)
- National Security (7)
- Net Zero (3)
- Neutron Science (102)
- Nuclear Energy (42)
- Partnerships (12)
- Physics (11)
- Polymers (12)
- Quantum Science (8)
- Renewable Energy (1)
- Simulation (4)
- Statistics (1)
- Summit (9)
- Sustainable Energy (69)
- Transportation (67)
Media Contacts
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.
By automating the production of neptunium oxide-aluminum pellets, Oak Ridge National Laboratory scientists have eliminated a key bottleneck when producing plutonium-238 used by NASA to fuel deep space exploration.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
Biologists from Oak Ridge National Laboratory and the Smithsonian Environmental Research Center have confirmed that microorganisms called methanogens can transform mercury into the neurotoxin methylmercury with varying efficiency across species.
Experts focused on the future of nuclear technology will gather at Oak Ridge National Laboratory for the fourth annual Molten Salt Reactor Workshop on October 3–4.
As leader of the RF, Communications, and Cyber-Physical Security Group at Oak Ridge National Laboratory, Kerekes heads an accelerated lab-directed research program to build virtual models of critical infrastructure systems like the power grid that can be used to develop ways to detect and repel cyber-intrusion and to make the network resilient when disruption occurs.
Brixon, Inc., has exclusively licensed a multiparameter sensor technology from the Department of Energy’s Oak Ridge National Laboratory. The integrated platform uses various sensors that measure physical and environmental parameters and respond to standard security applications.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.